Intelligent Bio Solutions INBS
NASDAQ INBS
$2.45 -0.20 (-7.36%)
As of: Aug 21, 2026 · 1:07 PM EDT

Intelligent Bio Solutions Inc. (INBS) Short term Debt (2020 - 2022)

Intelligent Bio Solutions (INBS) posted quarterly Short term Debt of $1.0 million for Q3 2022, up 1380.81% year-over-year from $68808.0 in Q3 2021, and down 64.08% quarter-over-quarter from $2.8 million in Q2 2022.

Intelligent Bio Solutions Inc. (INBS) Short term Debt (2020 - 2022) Analysis & Trends

Intelligent Bio Solutions' Short term Debt history runs 3 years deep, the most recent figure standing at $1.0 million for Q3 2022.

  • In Q3 2022, Short term Debt rose 1380.81% year-over-year to $1.0 million; the TTM figure through Sep 2022 stood at $1.0 million (up 1380.81% YoY), while the FY2022 annual figure was $2.8 million, up 21190.87% from the prior year.
  • Short term Debt for Q3 2022 stood at $1.0 million, down from $2.8 million in the prior quarter.
  • The five-year high for Short term Debt was $2.8 million in Q2 2022, with the low at $9536.0 in Q4 2021.
  • The 3-year median for Short term Debt is $250214.5 (2020), against an average of $773164.5.
  • The sharpest annual moves came in 2021 and 2022: Short term Debt sank 99.25% in 2021, then jumped 21190.87% in 2022.
  • Intelligent Bio Solutions' Short term Debt stood at $431621.0 in 2020, then plunged by 97.79% to $9536.0 in 2021, then jumped by 10584.96% to $1.0 million in 2022.
  • Business Quant data shows INBS's Short term Debt at $1.0 million in Q3 2022, $2.8 million in Q2 2022, and $9536.0 in Q4 2021.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2022 1.02 Mn
Jun 30, 2022 2.84 Mn
Dec 31, 2021 9,536.00
Sep 30, 2021 68,808.00
Jun 30, 2021 13,323.00
Mar 31, 2021 37,235.00
Dec 31, 2020 431,621.00
Jun 30, 2020 1.77 Mn